FDA Import Refusal 112-1503714-7/1/1 — Laboratoire Glaxosmithkline
The FDA refused shipment 112-1503714-7/1/1 from Laboratoire Glaxosmithkline (France) on Aug 22, 2008. The refused product falls under Drugs and Biologics — NARATRIPTAN TABLETS (ANALGESIC). Cited charge: 75
Refusal details
- Date
- Aug 22, 2008
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 60LCA86 NARATRIPTAN TABLETS (ANALGESIC)
- Charges
- 75